These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15197949)

  • 1. [Phosphate binding therapy].
    Kinugasa E; Ito H
    Nihon Rinsho; 2004 May; 62 Suppl 5():379-83. PubMed ID: 15197949
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients.
    Marco MP; Muray S; Betriu A; Craver L; Belart M; Fernández E
    Nephron; 2002 Oct; 92(2):499-500. PubMed ID: 12218343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sevelamer hydrochloride prevents ectopic calcification of blood vessels].
    Fukushima N; Nagano N
    Clin Calcium; 2004 Jun; 14(6):116-22. PubMed ID: 15577065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.
    Sturtevant JM; Hawley CM; Reiger K; Johnson DW; Campbell SB; Burke JR; Bofinger A; Isbel NM
    Nephrology (Carlton); 2004 Dec; 9(6):406-13. PubMed ID: 15663645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution in vitamin D treatment after debut of sevelamer hydrochloride in chronic renal failure patients].
    Suzuki M
    Clin Calcium; 2004 Sep; 14(9):60-3. PubMed ID: 15577112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular calcification progression -- a comparison of sevelamer and calcium-based phosphate binders.
    Raggi P
    Blood Purif; 2005; 23 Suppl 1():20-3. PubMed ID: 15832019
    [No Abstract]   [Full Text] [Related]  

  • 7. [Front line of management of hyperphosphatemia in hemodialysis patients].
    Yumita S
    Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
    Bover J; Ortiz-Herbener F; Ballarín J; Andrés E; Barceló P
    Nefrologia; 2005; 25 Suppl 2():100-8. PubMed ID: 16050412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hyperphosphataemia in chronic renal disease: lessons from the past and future directions.
    Amato M; Aterini S
    Nephrol Dial Transplant; 2003 Apr; 18(4):848; author reply 848-9. PubMed ID: 12637666
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention and treatment of secondary hyperparathyroidism: still a challenge for the nephrologist?
    Pavlović D; Brzac HT
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v45-6. PubMed ID: 12817069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interaction between sevelamer and cyclosporin.
    Guillen-Anaya MA; Jadoul M
    Nephrol Dial Transplant; 2004 Feb; 19(2):515. PubMed ID: 14736993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
    Novikov AI
    Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ischemic heart disease].
    Iseki K
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():246-9. PubMed ID: 15250302
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperparathyroidism in renal failure.
    Br Med J; 1978 Feb; 1(6110):390-1. PubMed ID: 624024
    [No Abstract]   [Full Text] [Related]  

  • 17. Periosteal new bone formation developing during haemodialysis for chronic renal failure.
    Ritchie WG; Winney RJ; Davison AM; Robson JS
    Br J Radiol; 1975 Aug; 48(572):656-61. PubMed ID: 810201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary hyperparathyroidism].
    Nakanishi S; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():341-6. PubMed ID: 16279659
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral calcium, sevelamer and vascular calcification in uraemic patients.
    Fournier A; Presne C; Oprisiu R; Sadek T
    Nephrol Dial Transplant; 2002 Dec; 17(12):2276-7. PubMed ID: 12454254
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.